Recombinant human bone morphogenetic protein-2 use in the off-label treatment of nonunions and acute fractures: A retrospective review

Journal of Trauma and Acute Care Surgery

Volumn 72, Issue 3, 2012, Pages 676-681

  Starman, James S ^a   Bosse, Michael J ^a   Cates, Casey A ^a   Norton, H James ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

BMP; Fracture; Nonunion

Indexed keywords

ANTIBIOTIC AGENT; COLLAGEN SPONGE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANTIBIOTIC THERAPY; ARTHRODESIS; BODY MASS; BONE ALLOGRAFT; BONE DEFECT; BONE RADIOGRAPHY; CONTROLLED STUDY; DEBRIDEMENT; FEMALE; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE; TIBIA SHAFT FRACTURE; TREATMENT FAILURE; TREATMENT OUTCOME; ACUTE DISEASE; ARTICLE; BIODEGRADABLE IMPLANT; COMPARATIVE STUDY; DRUG EFFECT; FOLLOW UP; FRACTURE; FRACTURE FIXATION; METHODOLOGY; MIDDLE AGED; OFF LABEL DRUG USE; RADIOGRAPHY;

ABSORBABLE IMPLANTS; ACUTE DISEASE; BONE MORPHOGENETIC PROTEIN 2; FEMALE; FOLLOW-UP STUDIES; FRACTURE FIXATION; FRACTURE HEALING; FRACTURES, CLOSED; FRACTURES, UNUNITED; HUMANS; MALE; MIDDLE AGED; OFF-LABEL USE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 84862670335     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e318232cf5a     Document Type: Review

References (14)

1. Musculoskeletal Injuries Report: Incidence, Risk Factors, and Prevention. Rosemont, IL: AAOS; 2000. Available at: Researchinfo@aaos.org.
2. Wiss DA, Johnson DL, Miao M. Compression plating for non-union after failed external fixation of open tibial fractures. J Bone Joint Surg Am. 1992;74:1279-1285.
3. Hetfet DL, Jupiter JB, Gasser S. Indirect reduction and tension-band plating of tibial non-union with deformity. J Bone Joint Surg Am. 1992;74:1286-1297.
4. Court-Brown CA, Keating JF, Christie J, McQueen MM. Exchange intramedullary nailing. Its use in aseptic tibial nonunion. J Bone Joint Surg Br. 1995;77:407-411.
5. Chapman MW, Finkemeier CG. Treatment of supracondylar nonunions of the femur with plate fixation and bone graft. J Bone Joint Surg Am. 1999;81:1217-1228.
6. De Long WG Jr, Einhorn TA, Koval K, et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am. 2007;89:649-658.
7. Greenwald AS, Boden SD, Goldberg VM, et al. Bone-graft substitutes: facts, fictions, and applications. J Bone Joint Surg Am. 2001; 83(Suppl 2, Pt 2):S98-S103.
8. De Biase P, Capanna R. Clinical applications of BMPs. Injury. 2005; 36(Suppl 3):S43-S46.
9. Govender S, Csimma C, Genant HK, et al; BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84:2123-2134.
10. Jones AL, Bucholz RW, Bosse MJ, et al; BMP-2 Evaluation in Surgery for Tibial Trauma-Allgraft (BESTT-ALL) Study Group. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am. 2006;88:1431-1441.
11. Riedel GE, Valentin-Opran A. Clinical evaluation of rhBMP-2/ACS in orthopedic trauma: a progress report. Orthopedics. 1999;22:663-665.
12. Swiontkowski MF, Aro HT, Donell S, et al. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am. 2006;88:1258-1265.
13. Geesink RG, Hoefnagels NH, Bulstra SK. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br. 1999;81:710-718.
14. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83(Suppl 1, Pt 2):S151-S158.